Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with Citrobacter rodentium

mSphere

Volumn 2, Issue 4, 2017, Pages

  Jiminez, Janelle A ^a,b   Uwiera, Trina C ^b   Wade Abbott, D ^a   Uwiera, Richard R E ^b   Inglis, G Douglas ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Butyrate; Citrobacter rodentium; Inflammation; Intestine; Mice; Microbiota

Indexed keywords

EID: 85041502837     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00243-17     Document Type: Article

References (87)

1. Lin HV, Frassetto A, Kowalik EJ, Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ. 2012. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7:e35240. https://doi.org/10.1371/journal.pone.0035240
2. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221-1227. https://doi.org/10.1136/gut.28.10 .1221
3. Cummings JH. 1984. Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol Suppl 93:89-99
4. Leonel AJ, Alvarez-Leite JI. 2012. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care 15:474-479. https://doi.org/ 10.1097/MCO.0b013e32835665fa
5. Barcelo A, Claustre J, Moro F, Chayvialle JA, Cuber JC, Plaisancié P. 2000. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 46:218-224. https://doi.org/10.1136/gut.46 .2.218
6. Gaudier E, Rival M, Buisine MP, Robineau I, Hoebler C. 2009. Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. Physiol Res 58:111-119
7. Pacheco RG, Esposito CC, Müller LC, Castelo-Branco MT, Quintella LP, Chagas VL, de Souza HS, Schanaider A. 2012. Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis. World J Gastroenterol 18:4278-4287. https:// doi.org/10.3748/wjg.v18.i32.4278
8. Shimotoyodome A, Meguro S, Hase T, Tokimitsu I, Sakata T. 2000. Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp Biochem Physiol A Mol Integr Physiol 125:525-531. https://doi.org/10.1016/S1095-6433(00)00183-5
9. D'Argenio G, Cosenza V, Delle Cave M, Iovino P, Delle Valle N, Lombardi G, Mazzacca G. 1996. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 110:1727-1734. https://doi.org/10.1053/gast.1996.v110.pm8964397
10. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. 2008. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104-119. https://doi.org/10.1111/j.1365-2036.2007 .03562.x
11. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. 2002. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217:133-139. https://doi.org/10.1111/j.1574-6968.2002.tb11467.x
12. Hamer HM, Jonkers DM, Renes IB, Vanhoutvin SA, Kodde A, Troost FJ, Venema K, Brummer RJ. 2010. Butyrate enemas do not affect human colonic MUC2 and TFF3 expression. Eur J Gastroenterol Hepatol 22: 1134-1140. https://doi.org/10.1097/MEG.0b013e32833a6ca0
13. Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C. 2012. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 7:e32841. https://doi.org/10.1371/journal.pone .0032841
14. Fung KY, Cosgrove L, Lockett T, Head R, Topping DL. 2012. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 108:820-831. https://doi.org/10.1017/S0007114512001948
15. Plöger S, Stumpff F, Penner GB, Schulzke JD, Gäbel G, Martens H, Shen Z, Günzel D, Aschenbach JR. 2012. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci 1258: 52-59. https://doi.org/10.1111/j.1749-6632.2012.06553.x
16. Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH, Liu K. 2012. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol 302:G1405-G1415. https://doi.org/10.1152/ajpgi.00543.2011
17. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. 2011. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17:1519-1528. https://doi.org/10.3748/ wjg.v17.i12.1519
18. Hýzd'alová M, Hofmanová J, Pacherník J, Vaculová A, Kozubík A. 2008. The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation. Cytokine 44:33-43. https://doi.org/10.1016/j.cyto.2008.06.003
19. Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, Kotani J. 2008. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res 28:321-328. https://doi.org/10.1016/j.nutres.2008.02.012
20. Hofmanová J, Straková N, Vaculová AH, Tylichová Z, Safaríková B, Skender B, Kozubík A. 2014. Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer. Mediators Inflamm 2014:848632. https://doi.org/10.1155/2014/848632
21. Liu J, Wang F, Luo H, Liu A, Li K, Li C, Jiang Y. 2016. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. Int Immunopharmacol 30:179-187. https://doi.org/10.1016/j.intimp .2015.11.018
22. Song M, Xia B, Li J. 2006. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J 82:130-135. https://doi.org/10 .1136/pgmj.2005.037945
23. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. 2010. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev 23:366-384. https://doi.org/10.1017/ S0954422410000247
24. Atuma C, Strugala V, Allen A, Holm L. 2001. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 280:G922-G929
25. Pelaseyed T, Bergström JH, Gustafsson JK, Ermund A, Birchenough GM, Schütte A, van der Post S, Svensson F, Rodríguez-Piñeiro AM, Nyström EE, Wising C, Johansson ME, Hansson GC. 2014. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev 260:8-20. https://doi.org/10.1111/imr.12182
26. Johansson ME, Larsson JM, Hansson GC. 2011. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 108(Suppl 1):4659-4665. https://doi.org/10.1073/pnas.1006451107
27. Belzer C, de Vos WM. 2012. Microbes inside-from diversity to function: the case of Akkermansia. ISME J 6:1449-1458. https://doi.org/10.1038/ ismej.2012.6
28. Robertson BR, O'Rourke JL, Neilan BA, Vandamme P, On SL, Fox JG, Lee A. 2005. Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. Int J Syst Evol Microbiol 55:1199-1204. https://doi .org/10.1099/ijs.0.63472-0
29. Wrzosek L, Miquel S, Noordine ML, Bouet S, Joncquel Chevalier-Curt M, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C, Langella P, Thomas M. 2013. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 11:61. https://doi.org/10.1186/1741-7007-11-61
30. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. 2010. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 5:e15046. https://doi.org/10 .1371/journal.pone.0015046
31. Schwab C, Berry D, Rauch I, Rennisch I, Ramesmayer J, Hainzl E, Heider S, Decker T, Kenner L, Müller M, Strobl B, Wagner M, Schleper C, Loy A, Urich T. 2014. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J 8:1101-1114. https://doi.org/10.1038/ismej.2013.223
32. Nielsen TS, Lærke HN, Theil PK, Sørensen JF, Saarinen M, Forssten S, Knudsen KE. 2014. Diets high in resistant starch and arabinoxylan modulate digestion processes and SCFA pool size in the large intestine and faecal microbial composition in pigs. Br J Nutr 112:1837-1849. https:// doi.org/10.1017/S000711451400302X
33. Kumar A, Alrefai WA, Borthakur A, Dudeja PK. 2015. Lactobacillus acidophilus counteracts enteropathogenic E. coli-induced inhibition of butyrate uptake in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 309:G602-G607. https://doi.org/10.1152/ajpgi.00186.2015
34. Costa E, Uwiera RR, Kastelic JP, Selinger LB, Inglis GD. 2011. Nontherapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responses. Gut Pathog 3:14. https://doi .org/10.1186/1757-4749-3-14
35. Bhinder G, Sham HP, Chan JM, Morampudi V, Jacobson K, Vallance BA. 2013. The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis. J Vis Exp 2013:e50222. https:// doi.org/10.3791/50222
36. Jiminez JA, Uwiera TC, Abbott DW, Uwiera RRE, Inglis GD. 2016. Impacts of resistant starch and wheat bran consumption on enteric inflammation in relation to colonic bacterial community structures and short-chain fatty acid concentrations in mice. Gut Pathog 8:67. https://doi.org/10 .1186/s13099-016-0149-6
37. Boets E, Deroover L, Houben E, Vermeulen K, Gomand SV, Delcour JA, Verbeke K. 2015. Quantification of in vivo colonic short chain fatty acid production from inulin. Nutrients 7:8916-8929. https://doi.org/10.3390/ nu7115440
38. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F, Mithieux G. 2014. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84-96. https://doi.org/10.1016/j.cell.2013.12.016
39. Weaver CT, Elson CO, Fouser LA, Kolls JK. 2013. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 8:477-512. https://doi.org/10.1146/annurev-pathol-011110-130318
40. Luperchio SA, Schauer DB. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3:333-340. https://doi.org/10.1016/S1286-4579(01)01387-9
41. Wang Z, Friedrich C, Hagemann SC, Korte WH, Goharani N, Cording S, Eberl G, Sparwasser T, Lochner M. 2014. Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium. Mucosal Immunol 7:1290-1301. https://doi .org/10.1038/mi.2014.17
42. Kojouharoff G, Hans W, Obermeier F, Männel DN, Andus T, Schölmerich J, Gross V, Falk W. 1997. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107:353-358. https:// doi.org/10.1111/j.1365-2249.1997.291-ce1184.x
43. Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G. 2014. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol 12:612-623. https://doi.org/10.1038/ nrmicro3315
44. Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, Huang T, Velcich A, Finlay BB, Chadee K, Vallance BA. 2010. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 6:e1000902. https://doi.org/10.1371/journal.ppat.1000902
45. Knodler LA, Bestor A, Ma C, Hansen-Wester I, Hensel M, Vallance BA, Steele-Mortimer O. 2005. Cloning vectors and fluorescent proteins can significantly inhibit Salmonella enterica virulence in both epithelial cells and macrophages: implications for bacterial pathogenesis studies. Infect Immun 73:7027-7031. https://doi.org/10.1128/IAI.73.10.7027-7031.2005
46. Tanoue T, Honda K. 2015. Regulation of intestinal Th17 and Treg cells by gut microbiota. Inflamm Regen 35:99-105. https://doi.org/10.2492/ inflammregen.35.099
47. Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, Ouyang W, Neurath MF, Becker C. 2010. Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle 9:652-655. https://doi.org/ 10.4161/cc.9.4.10615
48. Mizoguchi A. 2012. Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis 18:1777-1784. https://doi.org/10.1002/ibd.22929
49. Zhang M, Zhou Q, Dorfman RG, Huang X, Fan T, Zhang H, Zhang J, Yu C. 2016. Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol 16:84. https://doi.org/ 10.1186/s12876-016-0500-x
50. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282-289. https://doi.org/10.1038/nm1720
51. Saleh M, Trinchieri G. 2011. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 11:9-20. https:// doi.org/10.1038/nri2891
52. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV. 2011. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334:255-258. https://doi.org/10.1126/science.1209791
53. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569-573. https://doi.org/10.1126/science.1241165
54. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117-129. https://doi.org/10.1053/j.gastro.2006.04.020
55. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451-455. https://doi.org/10.1038/nature12726
56. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446-450. https://doi.org/10.1038/nature12721
57. Bergstrom KS, Xia L. 2013. Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology 23:1026-1037. https://doi.org/10 .1093/glycob/cwt045
58. Kles KA, Chang EB. 2006. Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure. Gastroenterology 130: S100-S105. https://doi.org/10.1053/j.gastro.2005.11.048
59. Hatayama H, Iwashita J, Kuwajima A, Abe T. 2007. The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochem Biophys Res Commun 356:599-603. https://doi.org/10.1016/j.bbrc.2007.03.025
60. Gaudier E, Jarry A, Blottière HM, de Coppet P, Buisine MP, Aubert JP, Laboisse C, Cherbut C, Hoebler C. 2004. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol 287:G1168-GG1174. https://doi.org/10.1152/ajpgi.00219.2004
61. Nair MG, Guild KJ, Du Y, Zaph C, Yancopoulos GD, Valenzuela DM, Murphy A, Stevens S, Karow M, Artis D. 2008. Goblet cell-derived resistinlike molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation. J Immunol 181:4709-4715. https://doi.org/10.4049/jimmunol.181.7.4709
62. Kim YS, Ho SB. 2010. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 12: 319-330. https://doi.org/10.1007/s11894-010-0131-2
63. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. 1995. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 109: 516-523. https://doi.org/10.1016/0016-5085(95)90340-2
64. Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD. 2004. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A 101:13596-13600. https://doi.org/10.1073/pnas.0404034101
65. Krimi RB, Kotelevets L, Dubuquoy L, Plaisancié P, Walker F, Lehy T, Desreumaux P, Van Seuningen I, Chastre E, Forgue-Lafitte ME, Marie JC. 2008. Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm Bowel Dis 14: 931-941. https://doi.org/10.1002/ibd.20420
66. Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, Karow ML, Ahrens R, Artis D, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rothenberg ME. 2006. Resistin-like molecule β regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 118:257-268. https://doi.org/10.1016/j.jaci.2006.04.039
67. + T cells during infectious colitis to promote protective intestinal epithelial cell proliferation. PLoS Pathog 11:e1005108. https://doi.org/10.1371/journal.ppat .1005108
68. Hoffmann C, Hill DA, Minkah N, Kirn T, Troy A, Artis D, Bushman F. 2009. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun 77:4668-4678. https://doi.org/10.1128/IAI.00493-09
69. Meehan CJ, Beiko RG. 2014. A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol Evol 6:703-713. https://doi.org/10.1093/gbe/ evu050
70. Derrien M, Van Baarlen P, Hooiveld G, Norin E, Müller M, de Vos WM. 2011. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol 2:166. https://doi.org/10.3389/fmicb.2011.00166
71. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110:9066-9071. https://doi.org/10.1073/pnas.1219451110
72. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Núñez G, Martens EC. 2016. A dietary fiberdeprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167:1339-1353.e21. https://doi.org/ 10.1016/j.cell.2016.10.043
73. Takao M, Yen H, Tobe T. 2014. LeuO enhances butyrate-induced virulence expression through a positive regulatory loop in enterohaemorrhagic Escherichia coli. Mol Microbiol 93:1302-1313. https://doi.org/10 .1111/mmi.12737
74. Franzin FM, Sircili MP. 2015. Locus of enterocyte effacement: a pathogenicity island involved in the virulence of enteropathogenic and enterohemorragic Escherichia coli subjected to a complex network of gene regulation. Biomed Res Int 2015:534738. https://doi.org/10.1155/2015/ 534738
75. Council NR. 2009. Recognition and alleviation of pain in laboratory animals. The National Academies Press, Washington, DC
76. Newman JV, Zabel BA, Jha SS, Schauer DB. 1999. Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice. Infect Immun 67:6019-6025
77. Playne MJ. 1985. Determination of ethanol, volatile fatty acids, lactic and succinic acids in fermentation liquids by gas chromatography. J Sci Food Agric 36:638-644. https://doi.org/10.1002/jsfa.2740360803
78. Cottyn BG, Boucque CV. 1968. Rapid method for the gas-chromatographic determination of volatile fatty acids in rumen fluid. J Agric Food Chem 16:105-107. https://doi.org/10.1021/jf60155a002
79. Illumina. 2013, posting date. 16S metagenomic sequencing library preparation. Illumina, San Diego, CA. https://support.illumina.com/ downloads/16s_metagenomic_sequencing_library_preparation.html
80. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335-336. https://doi.org/10.1038/nmeth.f.303
81. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. 2010. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26:266-267. https://doi.org/10.1093/bioinformatics/ btp636
82. Edgar RC. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:2460-2461. https://doi.org/10.1093/ bioinformatics/btq461
83. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P. 2012. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 6:610-618. https://doi.org/10.1038/ismej .2011.139
84. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. 2011. UniFrac: an effective distance metric for microbial community comparison. ISME J 5:169-172. https://doi.org/10.1038/ismej.2010.133
85. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19. https://doi.org/10.1186/gb-2007-8-2-r19
86. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RTPCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034. https://doi.org/10.1186/gb-2002-3-7-research0034
87. Johansson ME, Hansson GC. 2012. Preservation of mucus in histological sections, immunostaining of mucins in fixed tissue, and localization of bacteria with FISH. Methods Mol Biol 842:229-235. https://doi.org/10 .1007/978-1-61779-513-8_13